You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR CESAMET

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CESAMET

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00272207 ↗	A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia	Completed	Valeant Canada Limited	Phase 2	2006-04-01	The purpose of the study is to determine whether or not the drug Nabilone significantly reduces pain and improves quality of life in patients with fibromyalgia.
NCT00272207 ↗	A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia	Completed	Winnipeg Regional Health Authority	Phase 2	2006-04-01	The purpose of the study is to determine whether or not the drug Nabilone significantly reduces pain and improves quality of life in patients with fibromyalgia.
NCT00380913 ↗	Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy	Completed	NEMA Research, Inc.	Phase 4	2006-09-01	This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to diabetic peripheral neuropathy.
NCT00380965 ↗	Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Chemotherapy-Induced Neuropathy	Completed	NEMA Research, Inc.	Phase 4	2006-10-01	This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to chemotherapy-induced neuropathic pain in patients with cancer.
NCT00381264 ↗	Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Multiple Sclerosis	Completed	NEMA Research, Inc.	Phase 4	2006-09-01	This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to Multiple Sclerosis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CESAMET

Condition Name

Chart
Table

Condition Name for CESAMET
Intervention	Trials
Multiple Sclerosis	2
Obsessive-Compulsive Disorder	2
Diabetic Neuropathies	2
Fibromyalgia	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CESAMET
Intervention	Trials
Neuralgia	3
Obsessive-Compulsive Disorder	2
Compulsive Personality Disorder	2
Sclerosis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CESAMET

Trials by Country

Map
Table

Trials by Country for CESAMET
Location	Trials
Canada	9
United States	7
Mexico	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for CESAMET
Location	Trials
Florida	3
New York	2
Texas	1
Ohio	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CESAMET

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CESAMET
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	2
Phase 2/Phase 3	1
[disabled in preview]	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CESAMET
Clinical Trial Phase	Trials
Completed	8
Not yet recruiting	3
Unknown status	3
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CESAMET

Sponsor Name

Chart
Table

Sponsor Name for CESAMET
Sponsor	Trials
NEMA Research, Inc.	3
Bausch Health Americas, Inc.	3
Valeant Pharmaceuticals International, Inc.	3
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CESAMET
Sponsor	Trials
Other	21
Industry	10
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.